Acura Pharmaceuticals, Inc. (OTCMKTS:ACUR – Get Free Report) crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.00 and traded as high as $0.18. Acura Pharmaceuticals shares last traded at $0.02, with a volume of 18,200 shares.
Acura Pharmaceuticals Price Performance
Acura Pharmaceuticals Company Profile
Acura Pharmaceuticals, Inc, an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products.
See Also
- Five stocks we like better than Acura Pharmaceuticals
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- NVIDIA Stock Remains Stunningly Undervalued—Here’s Why
- How to Profit From Growth Investing
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- How to trade using analyst ratings
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
Receive News & Ratings for Acura Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acura Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
